160 related articles for article (PubMed ID: 26654409)
1. Using Neuroleptics to Treat Delirium in Dying Cancer Patients at a Cancer Center in Saudi Arabia.
Al-Shahri MZ; Sroor MY; Ghareeb WA; Aboulela EN; Edesa W
J Pain Palliat Care Pharmacother; 2015; 29(4):365-9. PubMed ID: 26654409
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic prescription pattern for delirium in patients with advanced cancer.
Hui D; Reddy A; Palla S; Bruera E
J Palliat Care; 2011; 27(2):141-7. PubMed ID: 21805949
[TBL] [Abstract][Full Text] [Related]
3. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.
Bascom PB; Bordley JL; Lawton AJ
Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790
[TBL] [Abstract][Full Text] [Related]
4. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Hui D; Frisbee-Hume S; Wilson A; Dibaj SS; Nguyen T; De La Cruz M; Walker P; Zhukovsky DS; Delgado-Guay M; Vidal M; Epner D; Reddy A; Tanco K; Williams J; Hall S; Liu D; Hess K; Amin S; Breitbart W; Bruera E
JAMA; 2017 Sep; 318(11):1047-1056. PubMed ID: 28975307
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptics in the management of delirium in patients with advanced cancer.
Hui D; Dev R; Bruera E
Curr Opin Support Palliat Care; 2016 Dec; 10(4):316-323. PubMed ID: 27661210
[TBL] [Abstract][Full Text] [Related]
6. The pattern of antimicrobial use for palliative care in-patients during the last week of life.
Abduh Al-Shaqi M; Alami AH; Zahrani AS; Al-Marshad B; Muammar AB; M Z AS
Am J Hosp Palliat Care; 2012 Feb; 29(1):60-3. PubMed ID: 21676985
[TBL] [Abstract][Full Text] [Related]
7. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes.
Briskman I; Dubinski R; Barak Y
Int Psychogeriatr; 2010 Mar; 22(2):328-31. PubMed ID: 19785917
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic dose in the management of delirium in patients with advanced cancer.
Hui D; Bush SH; Gallo LE; Palmer JL; Yennurajalingam S; Bruera E
J Pain Symptom Manage; 2010 Feb; 39(2):186-96. PubMed ID: 20152585
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
Hui D; De La Rosa A; Wilson A; Nguyen T; Wu J; Delgado-Guay M; Azhar A; Arthur J; Epner D; Haider A; De La Cruz M; Heung Y; Tanco K; Dalal S; Reddy A; Williams J; Amin S; Armstrong TS; Breitbart W; Bruera E
Lancet Oncol; 2020 Jul; 21(7):989-998. PubMed ID: 32479786
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?-a critical appraisal of recent randomized controlled trials.
Gaertner J; Eychmueller S; Leyhe T; Bueche D; Savaskan E; Schlögl M
Ann Palliat Med; 2019 Sep; 8(4):504-515. PubMed ID: 30943743
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
Elsayem A; Bush SH; Munsell MF; Curry E; Calderon BB; Paraskevopoulos T; Fadul N; Bruera E
J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301
[TBL] [Abstract][Full Text] [Related]
12. Delirium in the terminally ill.
Breitbart W; Strout D
Clin Geriatr Med; 2000 May; 16(2):357-72. PubMed ID: 10783433
[TBL] [Abstract][Full Text] [Related]
13. Delirium in palliative care.
Friedlander MM; Brayman Y; Breitbart WS
Oncology (Williston Park); 2004 Oct; 18(12):1541-50; discussion 1551-3. PubMed ID: 15609476
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with falls in patients with cancer hospitalized for palliative care.
Pautex S; Herrmann FR; Zulian GB
J Palliat Med; 2008 Jul; 11(6):878-84. PubMed ID: 18715180
[TBL] [Abstract][Full Text] [Related]
15. Current practice of pharmacological treatment for hyperactive delirium in terminally ill cancer patients: results of a nationwide survey of Japanese palliative care physicians and liaison psychiatrists.
Matsuda Y; Morita T; Oya K; Tagami K; Naito AS; Kashiwagi H; Otani H
Jpn J Clin Oncol; 2022 Aug; 52(8):905-910. PubMed ID: 35595535
[TBL] [Abstract][Full Text] [Related]
16. Psychopharmacology in supportive care of cancer: a review for the clinician: II. Neuroleptics.
Mazzocato C; Stiefel F; Buclin T; Berney A
Support Care Cancer; 2000 Mar; 8(2):89-97. PubMed ID: 10739354
[TBL] [Abstract][Full Text] [Related]
17. Controlled sedation for refractory symptoms in dying patients.
Mercadante S; Intravaia G; Villari P; Ferrera P; David F; Casuccio A
J Pain Symptom Manage; 2009 May; 37(5):771-9. PubMed ID: 19041216
[TBL] [Abstract][Full Text] [Related]
18. Lorazepam Added to Haloperidol Effective for Agitated Delirium in End-of-Life Cancer Patients.
Shrikant Kulkarni N
Am Fam Physician; 2018 Feb; 97(4):Online. PubMed ID: 29671522
[No Abstract] [Full Text] [Related]
19. Hydration management at the end of life.
Lanuke K; Fainsinger RL; DeMoissac D
J Palliat Med; 2004 Apr; 7(2):257-63. PubMed ID: 15130203
[TBL] [Abstract][Full Text] [Related]
20. Physician-reported corticosteroid therapy practices in certified palliative care units in Japan: a nationwide survey.
Matsuo N; Morita T; Iwase S
J Palliat Med; 2012 Sep; 15(9):1011-6; quiz 117-8. PubMed ID: 22734663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
